諾華公司 - 存託憑證（普通股）
DE ˙ DB ˙ US66987V1098
€121.00 0.00 (0.00%)
2026-06-04
分享價格
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionFragasso Group Inc.
Latest Disclosed Ownership1,540 shares
Latest Disclosed Value $ 235,374
Fragasso Group Inc. ownership in NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 7, 2026 - Fragasso Group Inc. filed a 13F-HR form disclosing ownership of 1,540 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $197,890 USD as of March 31, 2026. The entity filed a previous 13F-HR on May 14, 2020 disclosing 0 shares of Novartis AG - Depositary Receipt (Common Stock). The current value of the position is $186,340 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 1,540 1,540 235 0.0142
2020-05-14 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 0 -3,850 -100.00 0 -100.00
2020-02-13 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,850 0 0.00 365 8.96 0.0614
2019-11-13 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,850 0 0.00 335 -4.83 0.0621
2019-08-13 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,850 3,850 -70.17 352 -99.97 0.0696
2015-04-29 2015-03-31 13F Novartis COM 66987V109 0 -12,738 -100.00 0 -100.00
2015-01-21 2014-12-31 13F Novartis COM 66987V109 12,738 -167 -1.29 1,180 -2.80 1.0004
2014-11-03 2014-09-30 13F Novartis COM 66987V109 12,905 1,872 16.97 1,215 21.52 0.9477
2014-08-15 2014-06-30 13F Novartis COM 66987V109 11,033 182 1.68 999 8.23 0.8810
2014-08-15 2014-03-31 13F Novartis COM 66987V109 10,851 0 0.00 923 5.85 0.9511
2014-08-15 2013-12-31 13F Novartis COM 66987V109 10,851 10,851 872 0.7791
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.